• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阴道用脱氢表雄酮治疗绝经相关萎缩:证据回顾。

Vaginal DHEA to treat menopause related atrophy: a review of the evidence.

机构信息

Women's Health Research Program, School of Public Health and Preventive Medicine, Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, Victoria, Australia.

出版信息

Maturitas. 2011 Sep;70(1):22-5. doi: 10.1016/j.maturitas.2011.06.005. Epub 2011 Jul 5.

DOI:10.1016/j.maturitas.2011.06.005
PMID:21733647
Abstract

Vaginal atrophy is a common symptom of postmenopausal estrogen deficiency and can present as dryness, irritation, infection and dyspareunia and can affect sexual function and quality of life. Currently vaginal atrophy is treated with the intravaginal application of preparations containing estradiol or estriol, which are both effective and safe. It has been proposed that intravaginally administered dehydroepiandrosterone (DHEA) can be used to treat vaginal atrophy. DHEA and its sulphate DHEAS are the most abundant circulating sex steroid hormones in women, and provide a large precursor reservoir for the intracellular production of androgens and estrogens in non-reproductive tissues. Levels of DHEA and DHEAS decline with age. Although there is some evidence to support the use of intravaginal DHEA for postmenopausal women with symptoms of vaginal atrophy, independent studies are required to confirm this. In addition studies regarding the effects of vaginal DHEA on sexual function in women without vaginal atrophy are needed. Given that the efficacy and long term safety of low dose vaginal estradiol and estriol therapy is well established and that vaginal estrogen requires application of 2-3 times a week, rather than daily dosing; the benefit of daily vaginal DHEA over estrogen also needs to be considered as women may find it unpalatable to adhere to daily dosing with a cream preparation.

摘要

阴道萎缩是绝经后雌激素缺乏的常见症状,可表现为干燥、刺激、感染和性交困难,并会影响性功能和生活质量。目前,阴道萎缩采用含有雌二醇或雌三醇的阴道内制剂治疗,这些制剂既有效又安全。有人提出,可使用阴道内给予脱氢表雄酮(DHEA)来治疗阴道萎缩。DHEA 和其硫酸盐 DHEAS 是女性体内循环中最丰富的性激素,为非生殖组织中雄激素和雌激素的细胞内产生提供了大量前体储备。DHEA 和 DHEAS 的水平随年龄增长而下降。尽管有一些证据支持对有阴道萎缩症状的绝经后妇女使用阴道内 DHEA,但需要独立的研究来证实这一点。此外,还需要研究阴道 DHEA 对无阴道萎缩的女性性功能的影响。鉴于低剂量阴道雌二醇和雌三醇治疗的疗效和长期安全性已得到充分证实,并且阴道雌激素需要每周应用 2-3 次,而不是每天应用;因此,还需要考虑每日阴道 DHEA 相对于雌激素的益处,因为女性可能会发现难以接受每天用乳膏制剂进行阴道给药。

相似文献

1
Vaginal DHEA to treat menopause related atrophy: a review of the evidence.阴道用脱氢表雄酮治疗绝经相关萎缩:证据回顾。
Maturitas. 2011 Sep;70(1):22-5. doi: 10.1016/j.maturitas.2011.06.005. Epub 2011 Jul 5.
2
Dehydroepiandrosterone intra vaginal administration for the management of postmenopausal vulvovaginal atrophy.脱氢表雄酮经阴道给药治疗绝经后外阴阴道萎缩
J Steroid Biochem Mol Biol. 2015 Jan;145:139-43. doi: 10.1016/j.jsbmb.2014.09.003. Epub 2014 Sep 6.
3
Efficacy of intravaginal dehydroepiandrosterone (DHEA) on moderate to severe dyspareunia and vaginal dryness, symptoms of vulvovaginal atrophy, and of the genitourinary syndrome of menopause.阴道用脱氢表雄酮(DHEA)治疗中重度性交痛和阴道干燥、外阴阴道萎缩症状以及绝经后泌尿生殖系统综合征的疗效。
Menopause. 2018 Nov;25(11):1339-1353. doi: 10.1097/GME.0000000000001238.
4
Intravaginal dehydroepiandrosterone (Prasterone), a physiological and highly efficient treatment of vaginal atrophy.阴道内使用脱氢表雄酮(普拉睾酮),是一种治疗阴道萎缩的生理性且高效的方法。
Menopause. 2009 Sep-Oct;16(5):907-22. doi: 10.1097/gme.0b013e31819e8e2d.
5
DHEA for postmenopausal women: a review of the evidence.绝经后妇女的脱氢表雄酮治疗:证据回顾。
Maturitas. 2010 Jun;66(2):172-9. doi: 10.1016/j.maturitas.2009.12.017. Epub 2010 Jan 20.
6
Serum steroid levels during 12-week intravaginal dehydroepiandrosterone administration.阴道内给予脱氢表雄酮12周期间的血清类固醇水平。
Menopause. 2009 Sep-Oct;16(5):897-906. doi: 10.1097/gme.0b013e31819e8930.
7
Vaginal estrogen preparations: a review of safety and efficacy for vaginal atrophy.阴道雌激素制剂:阴道萎缩安全性与有效性综述
J Womens Health (Larchmt). 2002 Dec;11(10):857-77. doi: 10.1089/154099902762203704.
8
Comparison of intravaginal 6.5mg (0.50%) prasterone, 0.3mg conjugated estrogens and 10μg estradiol on symptoms of vulvovaginal atrophy.阴道内使用6.5毫克(0.50%)普拉睾酮、0.3毫克结合雌激素和10微克雌二醇对外阴阴道萎缩症状的比较。
J Steroid Biochem Mol Biol. 2017 Nov;174:1-8. doi: 10.1016/j.jsbmb.2017.03.014. Epub 2017 Mar 18.
9
High internal consistency and efficacy of intravaginal DHEA for vaginal atrophy.阴道内 DHEA 治疗阴道萎缩具有高内部一致性和疗效。
Gynecol Endocrinol. 2010 Jul;26(7):524-32. doi: 10.3109/09513590903511547.
10
DHEA, important source of sex steroids in men and even more in women.脱氢表雄酮(DHEA),男性性激素的重要来源,在女性中甚至更为重要。
Prog Brain Res. 2010;182:97-148. doi: 10.1016/S0079-6123(10)82004-7.

引用本文的文献

1
New Possibilities for Hormonal Vaginal Treatment in Menopausal Women.更年期女性激素阴道治疗的新可能性
J Clin Med. 2023 Jul 18;12(14):4740. doi: 10.3390/jcm12144740.
2
Testosterone positively regulates vagina NO-induced relaxation: an experimental study in rats.睾酮对阴道一氧化氮诱导的舒张起正向调节作用:一项大鼠实验研究。
J Endocrinol Invest. 2022 Jun;45(6):1161-1172. doi: 10.1007/s40618-022-01743-4. Epub 2022 Jan 24.
3
Vaginal dehydroepiandrosterone compared to other methods of treating vaginal and vulvar atrophy associated with menopause.
与其他治疗绝经相关阴道和外阴萎缩的方法相比,阴道脱氢表雄酮。
Prz Menopauzalny. 2020 Dec;19(4):195-199. doi: 10.5114/pm.2020.101943. Epub 2021 Jan 7.
4
Evaluation of the influence of chamomile vaginal gel on dyspareunia and sexual satisfaction in postmenopausal women: A randomized, double-blind, controlled clinical trial.洋甘菊阴道凝胶对绝经后女性性交困难和性满意度影响的评估:一项随机、双盲、对照临床试验。
Avicenna J Phytomed. 2020 Sep-Oct;10(5):481-491.
5
Treatment of genitourinary syndrome of menopause: the potential effects of intravaginal ultralow-concentration oestriol and intravaginal dehydroepiandrosterone on quality of life and sexual function.更年期泌尿生殖综合征的治疗:阴道内超低浓度雌三醇和阴道内脱氢表雄酮对生活质量和性功能的潜在影响。
Prz Menopauzalny. 2019 Jun;18(2):116-122. doi: 10.5114/pm.2019.86836. Epub 2019 Jun 28.
6
Herb Formula ZhenRongDan Balances Sex Hormones, Modulates Organ Atrophy, and Restores ER and ER Expressions in Ovariectomized Rats.中药制剂振蓉丹平衡性激素、调节器官萎缩并恢复去卵巢大鼠的雌激素受体(ER)及ER表达。
Evid Based Complement Alternat Med. 2018 Jun 13;2018:5896398. doi: 10.1155/2018/5896398. eCollection 2018.
7
Evaluation and Treatment of Female Sexual Pain: A Clinical Review.女性性疼痛的评估与治疗:临床综述
Cureus. 2018 Mar 27;10(3):e2379. doi: 10.7759/cureus.2379.
8
A survey of the therapeutic effects of Vitamin E suppositories on vaginal atrophy in postmenopausal women.维生素E栓剂对绝经后妇女阴道萎缩治疗效果的调查。
Iran J Nurs Midwifery Res. 2016 Sep-Oct;21(5):475-481. doi: 10.4103/1735-9066.193393.
9
Menopausal Symptoms and Their Management.更年期症状及其管理。
Endocrinol Metab Clin North Am. 2015 Sep;44(3):497-515. doi: 10.1016/j.ecl.2015.05.001.
10
In Silico Investigation of Cytochrome P450 2C9 in relation to Aging Using Traditional Chinese Medicine.基于中药的细胞色素 P450 2C9 与衰老关系的计算机研究
Evid Based Complement Alternat Med. 2014;2014:404505. doi: 10.1155/2014/404505. Epub 2014 May 8.